Dietary pterostilbene is a novel chemopreventive and therapeutic agent in prostate cancer: Pre-clinical studies

被引:0
|
作者
Levenson, Anait [1 ]
机构
[1] Long Isl Univ, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Brooklyn, NY USA
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2016年 / 252卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
178
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Optimizing STING Activity in Prostate Cancer Pre-Clinical Models
    Rajkumar, A. W.
    Wang, J.
    Chennupati, D. V.
    Kirschner, A. N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E233 - E233
  • [22] Enhanced therapeutic response to 177Lu-rhPSMA-10.1 in pre-clinical models of prostate cancer
    Vassileva, Vessela
    Gronlund, Rikke
    Waldron, Bradley
    Gauden, David
    Stevens, Daniel
    Foxton, Caroline
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [23] Oestrogen: A new chemopreventive agent for prostate cancer?
    Saul, Helen
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (12) : 1617 - 1617
  • [24] Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: Role of anti-inflammatory activity
    Krishnan, Aruna V.
    Moreno, Jacqueline
    Nonn, Larisa
    Swami, Srilatha
    Peehl, Donna M.
    Feldman, David
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : V74 - V80
  • [25] PRE-CLINICAL THERAPEUTIC MEASURES FOR THE ELDERLY
    LANG, E
    THERAPEUTISCHE UMSCHAU, 1981, 38 (01) : 8 - 13
  • [26] Therapeutic vaccination in chronic hepatitis B: pre-clinical studies in the woodchuck
    Roggendorf, M.
    Lu, M.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S6 - S6
  • [27] PRE-CLINICAL STUDIES - DISCUSSION
    MUGGIA
    UNVERFERTH
    LEVY
    JOHNSTON
    GURTOO
    HARRISON
    SEMINARS IN ONCOLOGY, 1983, 10 (01) : 46 - 48
  • [28] PRE-CLINICAL STUDIES IN A NOVEL SIDE-BRANCH STENT
    Banning, Amerjeet S.
    Gariety, Vincent
    Mouniemne, Karim
    Janus, Justyna
    Kelly, Michael
    Gunn, Julian P.
    Gershlick, Anthony H.
    HEART, 2017, 103 : A3 - A4
  • [29] Pre-clinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer
    Meredith, R.
    Buchsbaum, D.
    Alvarez, R.
    LoBuglio, A.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (04) : 397 - 397
  • [30] Pre-clinical development of the novel, broad spectrum, anti-cancer agent EL102
    McLaughlin, Fiona
    McLaughlin, Fiona
    CANCER RESEARCH, 2011, 71